Qtrilmet Європейський Союз - ісландська - EMA (European Medicines Agency)

qtrilmet

astrazeneca ab - sjúklingar stutt og long-term, saxagliptin, dapagliflozin - sykursýki, tegund 2 - lyf notuð við sykursýki - qtrilmet er ætlað í fullorðnir 18 ára og eldri með tegund sykursýki 2:til að bæta blóðsykursstjórnun þegar sjúklingar með eða án sulphonylurea (su) og annaðhvort saxagliptin eða dapagliflozin veitir ekki fullnægjandi blóðsykursstjórnun. þegar þegar í meðferð með sjúklingar og saxagliptin og dapagliflozin.

Celdoxome pegylated liposomal Європейський Союз - ісландська - EMA (European Medicines Agency)

celdoxome pegylated liposomal

yes pharmaceutical development services gmbh - doxórúbicín hýdróklóríð - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - Æxlishemjandi lyf - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Apomorfin PharmSwed Innrennslislyf, lausn 5 mg/ml Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

apomorfin pharmswed innrennslislyf, lausn 5 mg/ml

evolan pharma ab - apomorphin hýdróklóríð - innrennslislyf, lausn - 5 mg/ml

Bendamustine Accord Stofn fyrir innrennslisþykkni, lausn 2,5 mg/ml Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

bendamustine accord stofn fyrir innrennslisþykkni, lausn 2,5 mg/ml

accord healthcare b.v. - bendamustinum hýdróklóríð - stofn fyrir innrennslisþykkni, lausn - 2,5 mg/ml

Biorphen Stungulyf, lausn 10 mg/ml Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

biorphen stungulyf, lausn 10 mg/ml

sintetica gmbh - phenylephrinum hýdróklóríð - stungulyf, lausn - 10 mg/ml

Biorphen Stungulyf/innrennslislyf, lausn 0,1 mg/ml Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

biorphen stungulyf/innrennslislyf, lausn 0,1 mg/ml

sintetica gmbh - phenylephrinum hýdróklóríð - stungulyf/innrennslislyf, lausn - 0,1 mg/ml

Doxorubicin medac Innrennslislyf, lausn 2 mg/ml Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

doxorubicin medac innrennslislyf, lausn 2 mg/ml

medac gesellschaft für klinische spezialpräparate gmbh - doxorubicinum hýdróklóríð - innrennslislyf, lausn - 2 mg/ml

Irinotecan Accord Innrennslisþykkni, lausn 20 mg/ml Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

irinotecan accord innrennslisþykkni, lausn 20 mg/ml

accord healthcare b.v. - irinotecanum hýdróklóríð - innrennslisþykkni, lausn - 20 mg/ml

Ephedrine Sintetica Stungulyf, lausn 50 mg/ml Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

ephedrine sintetica stungulyf, lausn 50 mg/ml

sintetica gmbh - ephedrinum hýdróklóríð - stungulyf, lausn - 50 mg/ml